Funding

Sources of Funding, Updated June 2020

ICER’s mission is funded through a diverse combination of sources including grants, contracts, and unrestricted gifts from foundations and individuals; funding is not accepted from manufacturers or private insurers to perform reviews of specific treatments or therapies. ICER’s regional councils, CTAF, Midwest CEPAC and New England CEPAC are also funded by private foundations.  Since July 2019, ICER received funding from the following sources:

  • American Drug Utilization Review Symposium
  • Arnold Ventures
  • Blue Cross Blue Shield of Massachusetts
  • California Health Care Foundation
  • Commonwealth Fund
  • Eastern Medicaid Pharmacy Administrators Association
  • Harvard Pilgrim Health Care
  • JP Morgan
  • Kaiser Foundation Health Plan Inc.
  • Magellan Health
  • Mass Mutual Life Insurance Company
  • MorningStar
  • National Governors Association
  • National Health Council
  • National Institute for Health Care Management Research and Educational Foundation
  • National Institute of Health/University of Massachusetts Medical School
  • NESCSO/University of Massachusetts
  • Partners Healthcare
  • University of Illinois
  • Western Medicaid Pharmacy Administrators Association

Policy Leadership Forum Funding, Updated July 2020

ICER also receives support from pharmaceutical and health insurance companies for the annual ICER Policy Summit, Evidence Dialogue webinars, and other Policy Leadership Forum activities.  Current members include:

  • AbbVie
  • Alnylam Pharmaceuticals
  • America’s Health Insurance Plans (AHIP)
  • Anthem
  • AstraZeneca
  • Biogen
  • Blue Shield of California
  • Boehringer-Ingelheim
  • Cambia Health Solutions and MedSavvy
  • CVS Caremark
  • Editas
  • Envolve Pharmacy Solutions
  • Express Scripts
  • Genentech
  • GlaxoSmithKline
  • Harvard Pilgrim Health Care
  • Health Care Service Corporation (HCSC)
  • HealthFirst
  • Humana
  • Kaiser Permanente
  • LEO Pharma
  • Mallinckrodt Pharmaceuticals
  • Merck & Co.
  • National Pharmaceutical Council
  • Novartis
  • Premera Blue Cross
  • Prime Therapeutics
  • Pfizer
  • Regeneron
  • Sanofi
  • uniQure
  • United HealthCare